Press Releases

NEW YORK, Nov. 25, 2019 /PRNewswire/ -- The following event roundup from Virtual Press Office is a list of featured exhibitors for RSNA 2019, the world's premier radiology forum, which takes place from December 1 – 6 at McCormick Place in Chicago, Illinois. RSNA 2019

CHICAGO, Nov. 25, 2019 /PRNewswire/ -- Connectivity in an area of the brain that regulates emotion may be altered in infants exposed to opioids while in utero, according to a new study being presented next week at the annual meeting of the Radiological Society of North America (RSNA).Opioid use in pregnancy has become a major publi

CHICAGO, Nov. 25, 2019 /PRNewswire/ -- Researchers using MRI have found signs of damage that may be related to inflammation in the brains of obese adolescents, according to a study being presented next week at the annual meeting of the Radiological Society of North America (RSNA). Obesity in young people has become a significant pu

VANCOUVER, British Columbia, Nov. 25, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") announces that it has shipped Rêveur premium indoor flower line to its distribution partner, Fenix Logistics.

SOUTH PLAINFIELD, N.J., Nov. 25, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the United States Food and Drug Administration (FDA) has granted priority review for the New Drug Application (NDA) for risdiplam (RG7916) for the treatment of spinal muscular atrophy (SMA). The Prescription Drug User Fee Act (PDUFA) goal date for

Authorization for domestic and export purposes comes as a result of commercial quotas allocated to Khiron by the Colombian Technical Quotas Group ("TQG") for 2019 Permits Company to cultivate and commercialize psychoactive cannabis Includes authorization to export of whole plant extract to Uruguay and Brazil Positions Khiron

DALLAS, Nov. 24, 2019 /PRNewswire/ -- HealthMine, the health action engagement company, published a report today as part of its series on Medicare Advantage Plan Beneficiary Insights, entitled: "Closing Gaps to Create a Personalized Experience." The report covers five gaps between Medicare beneficiaries and their health plans. The reporting is based on a 2019 survey

HOUSTON, Nov. 24, 2019 /PRNewswire/ -- DNAtrix, a leader in the development of oncolytic viruses for cancer therapy, today presented updated safety and efficacy data from the fully-enrolled Phase 2 CAPTIVE / KEYNOTE-192 study of DNX-2401 (tasadenoturev), DNAtrix's oncolytic adenovirus, followed by pembrolizumab for patients with recurrent glioblastoma. The data

WILLOWBROOK, Ill., Nov. 23, 2019 /PRNewswire/ -- Pharmazz, Inc., a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients in critical care, today announced the initiation of dosing in its pivotal, phase 3 clinical trial evaluating sovateltide for the treatment of acute cerebral ischemic stroke. The first pa

NEW YORK, Nov. 23, 2019 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Sundial Growers Inc. ("Sundial" or the "Company")(NASDAQ:SNDL) of the November 25, 2019 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.